Neuroscience and biobehavioral reviewsApr 4, 2025

Brain changes linked to classic and non-classic psychedelics in lab and clinical studies

Psychedelic Science Weekly Brief ↗PubMed ↗DOI ↗

Updated Feb 15, 2026

Abstract

Psychedelics may enhance neuroplasticity, potentially serving as therapeutic targets for neuropsychiatric conditions.

Classic psychedelics like LSD and psilocybin, along with non-classic psychedelics such as ketamine and MDMA, are associated with rapid and lasting therapeutic effects.
Animal studies indicate that psychedelics can increase the nervous system's sensitivity to environmental stimuli, a phenomenon known as meta-plasticity.
These substances may also re-open developmental windows, enabling long-term structural changes in the brain, referred to as hyper-plasticity.
Challenges in translating findings to humans exist, primarily due to limitations in current imaging techniques.
Emerging research methods, including novel PET radioligands and non-invasive brain stimulation, could enhance understanding of psychedelics' impact on neuroplasticity.

Simplified

Neuroplasticity, the ability of the nervous system to adapt throughout an organism's lifespan, offers potential as both a biomarker and treatment target for neuropsychiatric conditions. Psychedelics, a burgeoning category of drugs, are increasingly prominent in psychiatric research, prompting inquiries into their mechanisms of action. Distinguishing themselves from traditional medications, psychedelics demonstrate rapid and enduring therapeutic effects after a single or few administrations, believed to stem from their neuroplasticity-enhancing properties. This review examines how classic psychedelics (e.g., LSD, psilocybin, N,N-DMT) and non-classic psychedelics (e.g., ketamine, MDMA) influence neuroplasticity. Drawing from preclinical and clinical studies, we explore the molecular, structural, and functional changes triggered by these agents. Animal studies suggest psychedelics induce heightened sensitivity of the nervous system to environmental stimuli (meta-plasticity), re-opening developmental windows for long-term structural changes (hyper-plasticity), with implications for mood and behavior. Translating these findings to humans faces challenges due to limitations in current imaging techniques. Nonetheless, promising new directions for human research are emerging, including the employment of novel positron-emission tomography (PET) radioligands, non-invasive brain stimulation methods, and multimodal approaches. By elucidating the interplay between psychedelics and neuroplasticity, this review informs the development of targeted interventions for neuropsychiatric disorders and advances understanding of psychedelics' therapeutic potential.

Full Text

Full text is available at the source.

View Full Text ↗

Brain changes linked to classic and non-classic psychedelics in lab and clinical studies

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the psychedelic science brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the psychedelic science brief